Boron neutron capture enhanced fast neutron radiotherapy for malignant gliomas and other tumors.
Both fast neutron radiotherapy and boron neutron capture therapy have been investigated as new radiation treatment techniques for patients with malignant gliomas. While each of these techniques individually has shown the potential for pathological eradication of malignant glioma, to date neither has evolved into an accepted, improved method of treatment. We have recently begun a research program investigating the feasibility of combining the benefits of both types of therapy. As a fast neutron beam penetrates tissue some of the particles are degraded to thermal energies. These can be captured by 10B or other suitable isotopes resulting in a highly-localized release of additional energy during a course of fast neutron radiotherapy. In this article we will review the rationale for such an approach, and review the underlying physics as well as in vitro, in vivo, and early human studies testing its feasibility. If appropriate carrier agents can be found that preferentially-localize in tumor cells, this approach ena be applied to many different tumor systems.
Buchholz
T A
TA
Department of Radiation Oncology, Wilford Hall Medical Center, Lackland AFB, TX 78236-5300, USA.
Laramore
G E
GE
Stelzer
K J
KJ
Risler
R
R
Wootton
P
P
Griffin
T W
TW
D000818:Animals; D001895:Boron; D016754:Boron Neutron Capture Therapy; D001932:Brain Neoplasms / Q000532:radiotherapy*; D002460:Cell Line; D002470:Cell Survival / Q000528:radiation effects; D006224:Cricetinae; D003412:Cricetulus; D005214:Fast Neutrons; D005240:Feasibility Studies; D005910:Glioma / Q000532:radiotherapy*; D006801:Humans; D007554:Isotopes; D051381:Rats
D007554:Isotopes; D001895:Boron